VynAssist | VYNDAMAX® (tafamidis) HCP Support

3 steps to VYNDAMAX access for your patients

Submit
Prior Authorization

Use CoverMyMeds to submit PAs or renewals electronically—at no cost.

Send Rx
to Specialty Pharmacy

Use your own IDN SPP if eligible or choose from our network of distribution partners.

VYNDAMAX
shipped to patient

Once approved, the medication is delivered directly to the patient’s home.

A VynAssist Access Care Manager provides a single point of contact for patients and their care teams

An Access Care Manager streamlines support for patients and their care teams throughout the VYNDAMAX access journey by:

Serving as a single point of contact for patients and care teams
Providing education about the insurance approval process and potential available financial assistance options, as appropriate
Supporting access and reimbursement coordination for patients who have opted in to an Access Care Manager,* including communicating when additional documentation or action may be required in the insurance process

Call 1-888-863-1177 (Mon-Fri, 8 AM-7 PM ET) to connect with a VynAssist Access Care Manager

Committed to helping your patients access their prescribed medication

Broad access
VYNDAMAX is widely accessible—more than 90% of patients with Medicare or commercial insurance can start on therapy^† after meeting standard prior authorization or formulary exception criteria.^‡ That means nearly every eligible prescribed patient has a path to treatment.

The VYNDAMAX SPP network has nationwide reach
VYNDAMAX is delivered through a powerful network of 6 national specialty pharmacies and over 175 integrated delivery networks (IDNs), ensuring patients receive their medication—wherever they are.

IDN=integrated delivery network; Rx=prescription; SPP=specialty pharmacy provider.
^*Available only for patients who opt in. Patients can opt in at myVynSupport.com.
^†Therapy=VYNDAMAX or VYNDAQEL ® (tafamidis meglumine).

^‡MMIT formulary data are current as of 07/2025. Data on file. Pfizer Inc, New York, NY, July 2025. The information provided is not a guarantee of coverage or payment (partial or full), and is subject to change without notice. Coverage may vary by region. Please confirm coverage with each patient's plan. The information in the linked prior authorization criteria documents is the sole responsibility of the plan sponsors. For additional information, consult the health plan website or official plan documentation. Pfizer Inc. does not control the content or intent behind these formulary restriction criteria. This information relates solely to formulary status and is not intended to imply that any mentioned products have comparable clinical efficacy or safety profiles or that products are interchangeable. Products may not have comparable FDA-approved indications.

VynAssist services are available to residents of the United States only. The product information provided in this site is intended only for healthcare professionals of the United States. The products discussed in this site may have different product labeling in different countries.

The health information in this site is for patients prescribed VYNDAMAX and is provided for educational purposes only. It is not intended to replace discussions with a healthcare provider. All decisions regarding patient care must be made with a healthcare provider, considering the unique characteristics of the patient.